Spectral Medical Provides August Tigris Trial Update

GlobeNewswireSep 3 19:30

Spectral Medical Posts $4.4 Million Loss in Second Quarter

MT NewswiresAug 9 22:00

Earnings Flash: Spectral Medical Q2 Revenue $471,000 Up From $306,000 in 2023

MT NewswiresAug 9 20:04

Spectral Medical Brief: Providing July Tigris Trial Update; 125 Patients Enrolled

MT NewswiresAug 1 20:03

Spectral Medical Brief: Says Net Proceeds From Offering Expected to Be Primarily Used by the Co on Its Phase III Registration Trial (Tigris) for Its PMX Treatment for Endotoxemic Septic Shock and for General Corporate and Working Capital Purposes

MT NewswiresJul 22 20:07

Spectral Medical Inc. Announces Closing of Additional US$1 Million Convertible Notes

GlobeNewswireJul 22 20:00